This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated keyaccountmanagement (KAM) strategies and capabilities to provide unique offerings and value. How should leading pharma companies respond? The Importance of Large, Organized Customers. References: 1.
She was medical lead at SIBAmed GmbH for four years. She has 20 years’ experience in business development and keyaccountmanagement in the clinical trials arena. Velocity acquired four clinical research sites in Europe from July 2022 onwards across the UK and Germany.
In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”. Marketing data will surpass health data as a leading signal for pharma advertisers.
I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up KeyAccountManagement at Boehringer-Ingelheim. My career started as an RGN, and I continue to work in the NHS in renal medicine. Focus on Service-Redesign.
When war broke out in Ukraine in early 2022, many clinical trial patients had to flee the country or relocate, presenting considerable disruption to existing clinical trials and risking data collection on medical products. “For For international clients, it’s just providing more information to reassure them. Credit: Oximio.
In US and Canada, sales employment is expected to increase in 2021 and 2022 due to increased vaccination and better immunization efforts but hiring was sharply decline during the pandemic. Many of them eventually climb up the organization rank and end up leading other sales reps as Sales Manager or make the transition to Product Manager.
According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content